Mehmet Oz

Mehmet Cengiz Oz's professional journey began with a strong foundation in medicine and surgery. After completing his residency at Presbyterian Hospital in New York, he co-founded its Cardiac Complementary Care Center. This initiative was forward-thinking, integrating complementary and alternative medicine (CAM) approaches for cardiac patients, a relatively novel concept in mainstream cardiology at the time.

His contributions extended to the development of innovative medical devices, most notably the MitraClip, a transcatheter mitral valve repair device that has revolutionized the treatment of mitral regurgitation. His academic prowess was recognized when he became a professor of surgery at Columbia University in 2001, a position he held until retiring as professor emeritus in 2018. This period cemented his reputation as a respected figure in surgical innovation and medical education, laying the groundwork for his subsequent public roles.

Oz's transition from the operating room to the television studio was a strategic pivot that amplified his reach exponentially. His initial appearances on 'The Oprah Winfrey Show,' beginning in 2003, showcased his ability to demystify complex health issues for a broad audience. This led to the launch of 'Second Opinion with Dr.

Oz' on the Discovery Channel and, more significantly, 'The Dr. Oz Show' in 2009. Produced by Harpo Productions and Sony Pictures Television, the daily program ran for 13 seasons and garnered 10 Daytime Emmy Awards, becoming a cultural phenomenon.

The show's success was built on its accessibility, offering practical health advice and engaging viewers in discussions about wellness, diet, and disease prevention. However, this widespread influence also brought scrutiny regarding the scientific validity of some of the topics discussed.

The immense popularity of 'The Dr. Oz Show' also placed Oz under a microscope, particularly concerning his promotion of certain health claims. Critics, including numerous medical publications and physicians, raised concerns about his advocacy for pseudoscience, including topics like alternative medicine, faith healing, and unsubstantiated weight-loss products.

The show faced accusations of promoting misinformation, leading to significant debate about journalistic ethics in health reporting and the responsibility of public figures. In 2015, he testified before a U.S. Senate subcommittee regarding the marketing of unproven dietary supplements. The institution of Columbia University eventually cut ties with Oz in May 2022, removing his faculty profile, signaling a divergence from his public persona and its associated controversies.

In 2022, Dr. Oz embarked on a new career path by running for the U.S. Senate in Pennsylvania as a Republican.

His candidacy was historic, as he was the first Muslim candidate to be nominated by either of the two major parties for a Senate seat. While he ultimately lost the election to the Democratic nominee, his political engagement demonstrated a desire to influence public policy. His career took another significant turn in 2025 when President Donald Trump appointed him as the 17th Administrator of the Centers for Medicare & Medicaid Services (CMS).

Confirmed by the Senate along party lines, this role places him in charge of a federal agency that plays a critical role in the U.S. healthcare system, overseeing Medicare, Medicaid, and the Children's Health Insurance Program, impacting the health coverage of millions of Americans.